2-methacryloyloxyethyl phosphorylcholine has been researched along with epidermal growth factor in 1 studies
| Studies (2-methacryloyloxyethyl phosphorylcholine) | Trials (2-methacryloyloxyethyl phosphorylcholine) | Recent Studies (post-2010) (2-methacryloyloxyethyl phosphorylcholine) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 240 | 3 | 145 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, N; Ishihara, K; Jinno, H; Kitagawa, Y; Shimada, T; Ueda, M; Wada, M; Watanabe, J | 1 |
1 other study(ies) available for 2-methacryloyloxyethyl phosphorylcholine and epidermal growth factor
| Article | Year |
|---|---|
Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Delivery Systems; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Infusions, Subcutaneous; Methacrylates; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Phosphorylcholine; Tissue Distribution; Tumor Cells, Cultured | 2009 |